---
title: "Preeclampsia"
subtitle: "First-trimester PAPP-A levels: influence of genetically determined ancestry and implications for preeclampsia prediction"
authors:
  - name: Dr Omar B Forge Risk
    affiliation: King's College London (Wellcome Trust), Imperial College London (NIHR)
    roles: Wellcome Trust CREATE Fellow \n NIHR Academic Clinical Fellow
    corresponding: Omar.Risk@kcl.ac.uk
format:
  revealjs:
      css: style.css
theme: serif
bibliography: references.bib
---

```{r}
#| label: load-packages
#| include: false
library(tidyverse)
library(gt)
```

## What's the scale of the problem?

MMR per 100,000 births. Population attributable fraction of [preeclampsia]{style="color:purple;"} and [haemorrhage]{style="color:red;"}.[^1]

[^1]: @knight2025; @hollier2024; @shafiq2024

::::::::: {.columns style="text-align:center"}
:::: {.column width="33%"}
::: fragment
![](images/gb.svg){width="25%"}\
![](images/UK_MMR.svg)
:::
::::

:::: {.column width="33%"}
::: fragment
![](images/zm.svg){width="25%"}\
![](images/ZM_MMR.svg)
:::
::::

:::: {.column width="33%"}
::: fragment
![](images/sl.svg){width="25%"}\
![](images/SL_MMR.svg)
:::
::::
:::::::::

## Preeclampsia is predictable

::::::::: {.columns style="text-align:center"}
:::: {.column width="33%"}
::: fragment
![](images/NICE.png){width="100%"}\
![](images/gb.svg){width="25%"}\
![](images/MatFac.svg){width="25%"}\
Detection rate: 40%
:::
::::

:::: {.column width="33%"}
::: fragment
![](images/papaya.png){width="50%"}\
![](images/sl.svg){width="25%"}\
![](images/MatFac.svg){width="25%"}\
Detection rate: \~5%
:::
::::

:::: {.column width="33%"}
::: fragment
![](images/FMF.png){width="100%"}\
![](images/gb.svg){width="25%"}\
![](images/MatFac.svg){width="25%"} ![](images/CRADLE.png){width="15%"}![](images/PLGF.png){width="25%"}![](images/UtA.png){width="15%"}\
Detection rate: 70%
:::
::::
:::::::::

## Preeclampsia is preventable

::::::::: {.columns style="text-align:center"}
::::: {.column width="50%"}
::: fragment
![](images/aspirin.png){width="70%"}
:::

::: fragment
![](images/sl.svg){width="25%"} ![](images/zm.svg){width="25%"}\
Uptake \~ 2%
:::
:::::

:::: {.column width="50%"}
::: fragment
![](images/aspirin_prevention.png){width="100%"}\
@rolnik2017
:::
::::

::: fragment
Early prediction enables us to target aspirin to delay severe preeclampsia and save lives.
:::
:::::::::

## Biomarkers help, but may require adjustment for ethnicity

:::::::: {.columns style="text-align:center"}
:::: {.column width="50%"}
::: fragment
![](images/plgf_ethnic.png){width="100%"}
:::
::::

:::: {.column width="50%"}
::: fragment
![](images/plgf_mom_ethnic.png){width="100%"}\
:::
::::

::: fragment
@wright2023
:::
::::::::

## West African GDA: independent risk for PE

![](images/GDA_PE.png){width="100%"}\
@conti-ramsden2024

## Research questions

::: fragment
-   Is there an independent association between GDA and levels of an angiogenic biomarker (PAPP-A)?
:::

::: fragment
-   If so, which ancestry group(s)?
:::

::: fragment
-   Can adjustment for GDA offer improved predictive utility for preeclampsia versus ethnicity alone?
:::

## Methods: sample

-   Case-Control sample (n = 5,207 after genomic QC)
-   ![](images/FMF.png){width="10%"} Harris Birthright Cohort
-   First trimester recruitment with follow-up to delivery
-   Case definition: early onset preeclampsia (n = 2,127)
-   Control definition: normotensive (n = 3,080)

## Methods: genomics

:::::: {style="font-size: 70%;"}
::: fragment
### Genotyping (Illumina GSA v3)

-   \~700,000 variants optimised for admixed populations
:::

::: fragment
### Calling (Illumina GenCall)

Â 
:::

::: fragment
### QC (Plink 1.9)

-   Sex discordance
-   Cryptic relatedness
-   Autosomal SNPs $< 5\%$ missing & MAF $> 1\%$
-   Population aggregated HWE P-value $> 10^{-4}$
:::
::::::

## Methods: genetically determined ancestry

-   Supervised ADMIXTURE v1.3 (1000G reference)
-   GDA: proportions sum to 1
-   26 populations (e.g. Yoruba)
-   5 superpopulations (e.g. African)
-   African regional populations (e.g. West African)

## Statistical Analysis

:::::: {style="font-size: 70%;"}
::: fragment
### Inference & feature selection

-   Inverse probability of selection weighting
-   Least Absolute Shrinkage and Selection Operator
:::

::: fragment
### Adjustment:

-   Unweighted LASSO among controls
-   $MoM($ PAPP-A $)_i = \frac{y_i}{\hat{y}_i}$
:::

::: fragment
### Prediction:

-   Univariate weighted logistic regression
-   (AU)ROC, bootstrap CI estimation (n = 2000)
:::
::::::

## Results: admixture

```{r stacked-bar, fig.cap="**Genetically estimated ancestry proportions among study cohort** (n = 5207).", echo=FALSE, fig.width=8, fig.height=2, out.width='100%'}
readRDS("../figures_plots/plots/stacked_bar.rds")
```

## Results: admixture

```{r GDA-scaled-density, fig.cap="**Scaled density of genetically estimated ancestry proportions among study cohort** (n = 5207).", echo=FALSE, fig.width=16, fig.height=8, out.width='100%'}
readRDS("../figures_plots/plots/density_GDA.rds") + theme(text = element_text(size = 25))
```

## Results: admixture

```{r sankey, fig.cap="**Sankey plot showing the reclassification of self-reported ethnicity by overall sample proportions of genetic ancestry estimates.**", echo=FALSE, message=FALSE, warnings=FALSE, fig.width=12, fig.height=7, out.width='100%'}
readRDS("../figures_plots/plots/sankey.rds")
```

## Results: PAPP-A discrimination

```{r PAPP-A-SRE-GDA, fig.cap="**Density of log10(PAPP-A) level in cases and controls by self reported ethnicity and strata of individual proportion of African superpopulation ancestry.** Red line indicates cutoff defined by a 10% screen positive rate in the overall sample.", echo=FALSE, message=FALSE, warnings=FALSE, fig.width=15, fig.height=7, out.width='100%'}
readRDS("../figures_plots/plots/PAPP_A_SRE_GDA.rds")
```

## Results: effects on PAPP-A

```{r inference-PAPP-A-1se, fig.cap="**Estimated OLS effects on log10(PAPP-A) of predictors selected by LASSO regression.**", echo=FALSE, message=FALSE, warnings=FALSE, fig.width=15, fig.height=7, out.width='100%'}
readRDS("../figures_plots/plots/inference_PAPP_A_1se.rds") + theme(text = element_text(size = 25))
```

## Results: prediction performance

```{r roc-curves, fig.cap="**Receiver operator curves for the accuracy of preeclampsia prediction by univariate logistic regression of MoM(PAPP-A).**", echo=FALSE, message=FALSE, warnings=FALSE, fig.width=11, fig.height=7}
readRDS("../figures_plots/plots/roc_curves.rds") + theme(text = element_text(size = 25))
```

## Results: prediction performance

```{r roc-tests, echo=FALSE, resuls='asis'}
readRDS("../figures_plots/tables/roc_tests.rds") %>% gt::tab_caption("Incremental comparison of the overall performance of screening for preeclampsia by PAPP-A, adjusted by different features.")
```

## Results: prediction performance

```{r detection-rates, echo=FALSE, resuls='asis'}
readRDS("../figures_plots/tables/detection_rates_wide.rds") %>% gt::tab_caption("Performance of fixed-cutoff screening for preeclampsia by PAPP-A, adjusted by different features. Cutoffs are fixed to achieve a screen positive rate of 50% among White women.")
```

## Thank you

::: {style="font-size: 70%;"}
### Supervisors:

-   **Dr Antonio de Marvao**
-   Dr Fran Conti-Ramsden (post-doc. QC & ADMIXTURE)

### Collaborators:

-   Prof Kypros Nicolaides (funding, cohort)
-   Dr Pirro Hysi (genotype calling)
:::

::: {style="height:1.2rem"}
:::

:::::::: {.columns style="text-align:center"}
::: {.column width="20%"}
![](images/Imperial.png)
:::

::: {.column width="20%"}
![](images/KCL.png)
:::

::: {.column width="20%"}
![](images/FMF.png)
:::

::: {.column width="20%"}
![](images/CREATE.png)
:::

::: {.column width="20%"}
![](images/NIHR.png)
:::
::::::::

## References